Discover open access scientific publications

Search, annotate, share and cite publications

Publications by James Lee Murray

Developing Anti-Her2 Vaccines: Breast Cancer Experience

International Journal of Cancer

Cancer Research

Oncology

2018

English

Related publications

Brain Metastases in Asian HER2-positive Breast Cancer Patients: Anti-Her2 Treatments and Their Impact on Survival

British Journal of Cancer

Cancer Research

Oncology

2012

English

Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer

Oncotarget

Oncology

2017

English

HER2 Expression in NF1 Breast Cancer—Response

Cancer Prevention Research

English

Benefit of Post Mastectomy Radiation Therapy (PMRT) in Node-Positive, HER2-Positive Patients With Breast Cancer Receiving Anti-Her2 Treatments

International Journal of Radiation Oncology Biology Physics

English

BioPATH: A Biomarker Study in Asian Patients With HER2+ Advanced Breast Cancer Treated With Lapatinib and Other Anti-Her2 Therapy

Cancer Research and Treatment

Cancer Research

Oncology

2019

English

T-Dm1 Reduces HER2+ Breast Cancer Recurrence

Cancer Discovery

Oncology

2018

English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology

English

Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity Against Breast Cancer Models Resistant to Anti-Her2 Drugs

PLoS ONE

Multidisciplinary

2015

English

Loss of HER2 Positivity After Anti-Her2 Chemotherapy in HER2-positive Gastric Cancer Patients: Results of the GASTric Cancer HER2 Reassessment Study 3 (GASTHER3)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by James Lee Murray

Developing Anti-Her2 Vaccines: Breast Cancer Experience

Related publications

Brain Metastases in Asian HER2-positive Breast Cancer Patients: Anti-Her2 Treatments and Their Impact on Survival

Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer

HER2 Expression in NF1 Breast Cancer—Response

Benefit of Post Mastectomy Radiation Therapy (PMRT) in Node-Positive, HER2-Positive Patients With Breast Cancer Receiving Anti-Her2 Treatments

BioPATH: A Biomarker Study in Asian Patients With HER2+ Advanced Breast Cancer Treated With Lapatinib and Other Anti-Her2 Therapy

T-Dm1 Reduces HER2+ Breast Cancer Recurrence

Targeted Therapy for HER2 Positive Breast Cancer

Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity Against Breast Cancer Models Resistant to Anti-Her2 Drugs

Loss of HER2 Positivity After Anti-Her2 Chemotherapy in HER2-positive Gastric Cancer Patients: Results of the GASTric Cancer HER2 Reassessment Study 3 (GASTHER3)